Recordati Updates on Share Buyback Program Execution

Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has shared an announcement.

Recordati S.p.A. has updated the market on its ongoing share buyback program, initiated to support its stock options and performance share plans. The company purchased 89,172 ordinary shares between June 16 and June 20, 2025, reflecting a strategic move to enhance shareholder value and support future incentive plans.

The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.

More about Recordati Industria Chimica e Farmaceutica SPA

Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic solutions in specialty and general medicine, as well as rare diseases, and operates across the EMEA, Americas, and APAC regions with over 4,580 employees.

Average Trading Volume: 369,429

Technical Sentiment Signal: Strong Buy

Current Market Cap: €11.13B

For detailed information about REC stock, go to TipRanks’ Stock Analysis page.